Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 9 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Mirum Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 117 | 146 | +29 |
| Shares | 34.7M | 36.9M | +2.27M (+6.5%) |
| Value | $832.9M | $955.6M | +$122.8M (+14.7%) |
New holders (38)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (9)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 2,032,335 | $48.8M |
| Wellington Management Group LLP | 154,750 | $3.72M |
| Sphera Funds Management Ltd. | 109,336 | $2.63M |
| Repertoire Partners LP | 49,900 | $1.20M |
| Millennium Management LLC | 15,363 | $369.0K |
| Ergoteles LLC | 12,012 | $288.5K |
| Balyasny Asset Management LLC | 10,250 | $246.2K |
| Values First Advisors, Inc. | 8,497 | $204.1K |
| Belpointe Asset Management LLC | 2,800 | $67.3K |